Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage

Journal of Experimental Medicine

Volumn 188, Issue 6, 1998, Pages 1005-1016

  Lupetti, Raffaella ^a   Pisarra, Patrizia ^a   Verrecchia, Alessandro ^b   Farina, Cinthia ^a   Nicolini, Gabriella ^a   Anichini, Andrea ^a   Bordignon, Claudio ^b   Sensi, Marialuisa ^a   Parmiani, Giorgio ^a   Traversari, Catia ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Intron encoded epitope; Melanoma; Specificity; T cell

Indexed keywords

MELANOMA ANTIGEN; MONOPHENOL MONOOXYGENASE;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; INTRON; MELANOMA; PRIORITY JOURNAL;

ALLELES; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; BASE SEQUENCE; CLONING, MOLECULAR; COS CELLS; DNA, COMPLEMENTARY; EPITOPES; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTOCOMPATIBILITY TESTING; HLA-A3 ANTIGEN; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; INTRONS; MELANOCYTES; MELANOMA; MOLECULAR SEQUENCE DATA; PEPTIDES; POLYMERASE CHAIN REACTION; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0032555951     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.6.1005     Document Type: Article

References (43)

1. Van den Eynde, B.J., and P. van der Bruggen. 1997. T cell defined tumor antigens. Curr. Opin. Immunol. 9:684-693.
2. Rosenberg, S.A., J.R. Yannelli, J.C. Yang, S.L. Topalian, D.J. Schwartzentruber, J.S. Weber, D.R. Parkinson, C.M. Seipp, J.H. Einhorn, and D.E. White. 1994. Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin-2. J. Natl. Cancer Inst. 86:1159-1166.
3. Arienti, F., F. Belli, L. Rivoltini, C. Gambacorti-Passerini, L. Furlan, L. Mascheroni, A. Prada, M. Rizzi, E. Marchesi, M. Vaglini, et al. 1993. Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL-2. Cancer Immunol. Immunother. 36:315-322.
4. Marchand, M., P. Weynants, E. Rankin, F. Arienti, F. Belli, G. Parmiani, N. Cascinelli, A. Bourlond, R. Vanwijck, Y. Humblet, et al. 1995. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer. 63:883-885.
5. Rosenberg, S.A., J.C. Yang, D.J. Schwartzentruber, P. Hwu, F.M. Marincola, S.L. Topalian, N.P. Restifo, M.E. Dudley, S.L. Schwarz, P.J. Spiess, et al. 1998. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med. 4:321-327.
6. Nestle, F.O., S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, R. Dummer, G. Burg, and D. Schadendorf. 1998. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat. Med. 4:328-333.
7. Jäger, E., Y.T. Chen, J.W. Drijfhout, J. Karbach, M. Ringhoffer, D. Jäger, M. Arand, H. Wada, Y. Noguchi, E. Stockert, et al. 1998. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human-histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J. Exp. Med. 187:265-270.
8. Takahashi, K., S. Shichijo, M. Noguchi, M. Hirohata, and K. Itoh. 1995. Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res. 55:3478-3482.
9. Haas, G.G., Jr., O.J. D'Cruz, and L.E. De Bault. 1988. Distribution of human leukocyte antigen-ABC and -D/DR antigens in the unfixed human testis. Am. J. Reprod. Immunol. Microbiol. 18:47-51.
10. Robbins, P.F., M. El-Gamil, Y.F. Li, E.B. Fitzgerald, Y. Kawakami, and S.A. Rosenberg. 1997. The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor infiltrating lymphocytes. J. Immunol. 159:303-308.
11. Wang, R.F., P.F. Robbins, Y. Kawakami, X. Kang, and S.A. Rosenberg. 1995. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J. Exp. Med. 181:799-804.
12. Wang, R.F., E. Appella, Y. Kawakami, X. Kang, and S.A. Rosenberg. 1996. Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J. Exp. Med. 184:2207-2216.
13. Sugita, S., K. Sagawa, M. Mochizuchi, S. Shichijo, and K. Itoh. 1996. Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease. Int. Immunol. 8: 799-803.
14. Anichini, A., R. Mortarini, C. Maccalli, P. Squarcina, K. Fleischhauer, L. Mascheroni, and G. Parmiani. 1996. Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma. J. Immunol. 156:208-217.
15. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods. 95:99-105.
16. Coulie, P.G., F. Lehmann, B. Lethé, J. Herman, C. Lurquin, M. Andrawiss, and T. Boon. 1995. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. Natl. Acad. Sci. USA. 92:7976-7980.
17. Yokoyama, K., H. Suzuki, K. Yasumoto, Y. Tomita, and S. Shibahara. 1994. Molecular cloning and functional analysis of a cDNA coding for human DOPAchrome tautomerase/tyrosinase-related protein-2. Biochim. Biophys. Acta. 1217:317-321.
18. Traversari, C., P. van der Bruggen, B. Van den Eynde, P. Hainaut, C. Lemoine, N. Ohta, L. Old, and T. Boon. 1992. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics. 35:145-152.
19. Fleischhauer, K., S. Tanzarella, V. Russo, M.L. Sensi, P. van der Bruggen, C. Bordignon, and C. Traversari. 1997. Functional heterogeneity of HLA-A(Black star)02 subtypes revealed by presentation of a MAGE-3-encoded peptide to cytotoxic T cell clones. J. Immunol. 159:2513-2521.
20. Weynants, P., B. Lethé, F. Brasseur, M. Marchand, and T. Boon. 1994. Expression of MAGE genes by non-small-cell lung carcinomas. Int. J. Cancer. 56:826-829.
21. Donghi, R., A. Longoni, S. Pilotti, P. Michieli, G. Della Porta, and M. Pierotti. 1993. Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J. Clin. Invest. 4:1753-1760.
22. Huang, Z., M.J. Fasco, and L. Kaminsky. 1996. Optimization of Dnase I removal of contaminating DNA from RNA for use in quantitative RNA-PCR. Biotechniques. 20:1012-1020.
23. Adema, G.J., A.J. de Boer, A.M. Vogel, W.A.M. Loenen, and C.G. Figdor. 1994. Molecular characterization of the melanocyte lineage-specific antigen gp100. J. Biol. Chem. 269:20126-20133.
24. Hecker, K.H., and K.H. Roux. 1996. High and low annealing temperatures increase both specificity and yield in touchdown and stepdown PCR. Biotechniques. 20:478-485.
25. Oh, S., K. Fleischhauer, and S. Yang. 1993. Isoelectric focusing subtypes of HLA-A can be defined by oligonucleotide typing. Tissue Antigens. 41:135-142.
26. Sturm, R.A., B.J. O'Sullivan, N.F. Box, A.G. Smith, S.E. Smit, E.R. Puttick, P.G. Parsons, and I.S. Dunn. 1995. Chromosomal structure of the human TYRP1 and TYRP2 loci and comparison of the tyrosinase-related protein gene family. Genomics. 29:24-34.
27. Rammensee, H.G., T. Friede, and S. Stefanovic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics. 41:178-228.
28. Sidney, J., H.M. Grey, S. Southwood, E. Celis, P.A. Wentworth, M.F. del Guercio, R.T. Kubo, R.W. Chesnut, and A. Sette. 1996. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires ot common HLA molecules. Hum. Immunol. 45:79-93.
29. Wang, R.F., M.R. Parkhurst, Y. Kawakami, P.F. Robbins, and S.A. Rosenberg. 1996. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen. J. Exp. Med. 183:1131-1140.
30. Guilloux, Y., S. Lucas, V.G. Brichard, A. Van Pel, C. Viret, E. De Plaen, F. Brasseur, B. Lethé, F. Jotereau, and T. Boon. 1996. A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene. J. Exp. Med. 183:1173-1183.
31. Bullock, T.N., and L.C. Eisenlohr. 1996. Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames. J. Exp. Med. 184:1319-1329.
32. Le Fur, N., S.R. Kelsall, W.K. Silvers, and B. Mintz. 1997. Selective increase in specific alternative splice variants of tyrosinase in murine melanomas: a projected basis for immunotherapy. Proc. Natl. Acad. Sci. USA. 94:5332-5337.
33. Eberle, J., C. Garbe, N. Wang, and C.E. Orfanos. 1995. Incomplete expression of the tyrosinase gene family (tyrosinase, TRP-1, and TRP-2) in human malignant melanoma cells in vitro. Pigm. Cell Res. 8:307-313.
34. Dirksen, W.P., Q. Sun, and F.M. Rottman. 1995. Multiple splicing signals control alternative intron retention of bovine growth hormone pre-mRNA. J. Biol. Chem. 270:5346-5352.
35. Lang, K.M., V.L. van Santen, and R.A. Spritz. 1985. The two intervening sequences of human β-and γ-globin pre-mRNA are excised in a preferred temporal order in vitro. EMBO (Eur. Mol. Biol. Organ.) J. 4:1991-1996.
36. Tsukamoto, K., I. Jackson, K. Urabe, P. Montague, and V. Hearing. 1992. A second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed DOPAchrome tautomerase. EMBO (Eur. Mol. Biol. Organ.) J. 11:519-526.
37. Lethé, B., P. van der Bruggen, F. Brasseur, and T. Boon. 1997. MAGE-1 expression threshold for the lysis of melanoma cell lines by a specific cytotoxic T lymphocyte. Melanoma Res. 7(Suppl. 2):S83-S88.
38. Labarriere, N., E. Diez, M.C. Pandolfino, C. Viret, Y. Guilloux, S. Le Guiner, J.F. Fonteneau, B. Dreno, and F. Jotereau. 1997. Optimal T cell activation by melanoma cells depends on a minimal level of antigen transcription. J. Immunol. 158:1238-1245.
39. Schwartz, R. 1989. Acquisition of immunologic self-tolerance. Cell. 57:1073-1081.
40. Slingluff, C., D. Hunt, and V. Engelhard. 1994. Direct analysis of tumor-associated peptide antigens. Curr. Opin. Immunol. 6:733-740.
41. Sidney, J., M.F. del Guercio, S. Southwood, V. Engelhard, E. Appella, H. Rammensee, K. Falk, O. Rotzschke, M. Takiguchi, R.T. Kubo, et al. 1995. Several HLA alleles share overlapping peptide specificities. J. Immunol. 154:247-259.
42. Missale, G., A. Redeker, J. Person, P. Fowler, S. Guilhot, H.J. Schlicht, C. Ferrari, and F.V. Chisari. 1993. HLA-A31-and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J. Exp. Med. 177:751-762.
43. Wang, R.F., S.L. Johnston, S. Southwood, A. Sette, and S.A. Rosenberg. 1998. Recognition of an antigenic peptide derived from tyrosinase-related protein-2 by CTL in the context of HLA-A31 and -A33. J. Immunol. 160:890-897.